Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000535996 | SCV000576643 | benign | not provided | 2020-06-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001837929 | SCV000659293 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000535996 | SCV001133413 | benign | not provided | 2018-11-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002356800 | SCV002660502 | likely benign | Cardiovascular phenotype | 2018-09-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000535996 | SCV004562132 | likely benign | not provided | 2023-11-25 | criteria provided, single submitter | clinical testing | |
GENin |
RCV004584729 | SCV005074085 | benign | Familial hypercholesterolemia | 2023-09-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535543 | SCV004743613 | likely benign | APOB-related disorder | 2019-03-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |